[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613004":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":38,"responsibleParty":67,"collaborators":11,"id":69,"slug":11,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":76,"maxAge":11,"enrollmentInfo":77,"targetDuration":11,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":41,"whyStopped":11,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"University Hospital, Bordeaux","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Systemic lupus erythematosus (SLE)","EXPERIMENTAL",null,[13],"Biological: blood sample",{"label":15,"type":16,"description":11,"interventionNames":17},"Rheumatoid arthritis or an inflammatory bowel","ACTIVE_COMPARATOR",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":11},"BIOLOGICAL","blood sample","30 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation",[15,9],[25],{"name":26,"affiliation":5,"role":27},"Christophe RICHEZ, Prof","PRINCIPAL_INVESTIGATOR",[29,34],{"name":26,"role":30,"phone":31,"phoneExt":32,"email":33},"CONTACT","(0)5 56 79 55 56","+33","christophe.richez@chu-bordeaux.fr",{"name":35,"role":30,"phone":36,"phoneExt":32,"email":37},"Thomas BARNETCHE, PhD","(0)5.57.82.04.93","thomas.barnetche@chu-bordeaux.fr",[39],{"facility":40,"status":41,"city":42,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"CHU de Bordeaux - service de rhumatologie","RECRUITING","Bordeaux","France","FR",{"type":46,"coordinates":47},"Point",[48,49],-0.58046,44.84124,{"lat":49,"lon":48},[52,54,55,56,59,61,63,65],{"name":26,"role":30,"phone":53,"phoneExt":32,"email":33},"(0)5.56.79.55.56",{"name":35,"role":30,"phone":36,"phoneExt":32,"email":37},{"name":26,"role":27,"phone":11,"phoneExt":11,"email":11},{"name":57,"role":58,"phone":11,"phoneExt":11,"email":11},"Lionel COUZI, Prof","SUB_INVESTIGATOR",{"name":60,"role":58,"phone":11,"phoneExt":11,"email":11},"Julien SENESCHAL, Prof",{"name":62,"role":58,"phone":11,"phoneExt":11,"email":11},"Noemie GENSOUS, MD",{"name":64,"role":58,"phone":11,"phoneExt":11,"email":11},"Estibaliz LAZARO, Prof",{"name":66,"role":58,"phone":11,"phoneExt":11,"email":11},"Pauline RIVIERE, MD",{"type":68,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100613004",false,"NCT07260942","Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus","FERROLUP","Inclusion Criteria:\n\n* age ≥ 18 years;\n* diagnosis of systemic lupus erythematosus;\n* being affiliated to health insurance, willing to participate and to sign informed consent;\n* control group : patients with a diagnosis of rheumatoid arthritis or an inflammatory bowel disease.\n\nExclusion Criteria:\n\n* pregnant or breastfeeding women;\n* patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).","ALL","18 Years",{"count":78,"type":79},120,"ESTIMATED","INTERVENTIONAL",[82],"NA","The study aims at defining the role of ferroptosis s in the physiopathology of systemic lupus erythematosus (SLE). Ferroptosis (phenomenon of cellular death regulated by iron) is a metabolic pathway potentially implicated in SLE with potential for the discovery of new therapeutic strategies.",[85],"Systemic Lupus Erythematosus",[87,88,89],"Systemic lupus erythematosus","ferroptosis","autoimmunity","2026-05-13",{"date":92,"type":93},"2026-05-18","ACTUAL",{"date":95,"type":93},"2026-04-21",{"date":97,"type":79},"2029-04",{"name":5,"class":6},1]